Cytosorbents (NASDAQ:CTSO – Get Free Report)‘s stock had its “buy” rating restated by D. Boral Capital in a research report issued on Friday,Benzinga reports. They currently have a $10.00 price ...
Some results have been hidden because they may be inaccessible to you